Pricing Log in Create free account
Friday 6 November 2026 Export PLSE’s income statement to Excel — free account

Pulse Biosciences, Inc

PLSE Healthcare Medical Instruments & Supplies

Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022.

Revenue
+359.3%
EPS
−10.3%
Free cash flow
−1,180.5%

Quarter to September 2026, against a year earlier

51.30 1.77 −3.34%
Market cap
$3.9B
P/E
0.0×
Fwd P/E
−38.1×
Dividend yield
—
F-score
n/a
Altman Z
31.41
Beneish M
n/a
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Pulse Biosciences, Inc (PLSE) Revenue

Alert me on Revenue

Pulse Biosciences, Inc's revenue for fiscal 2025 was $350.0K, down 50.0% from $700.0K in fiscal 2022. Over the twelve months to 30 September 2026 it was $1.5M. Pulse Biosciences, Inc ranks 45th of 47 Medical Instruments & Supplies companies by revenue.

Revenue, annual

Embed this chart

Annual newest first

Period Revenue Change
FY2025 $350.0K (50.00%)
FY2022 $700.0K (50.63%)
FY2021 $1.4M —

Quarterly newest first

Period Revenue Change
Sep 2026 $395.0K (8.99%)
Jun 2026 $434.0K 8.23%
Mar 2026 $401.0K 51.89%
Dec 2025 $264.0K 206.98%
6 more quarters

Revenue against peers

Company Revenue
MMED MiniMed Group, Inc. compare $3.0B
NVST Envista Holdings Corporation compare $2.9B
TFX Teleflex Incorporated compare $2.3B
ICUI ICU Medical, Inc. compare $2.2B
MMSI Merit Medical Systems, Inc. compare $1.6B
STVN Stevanato Group S.p.A. compare $1.4B
WRBY Warby Parker Inc. compare $934.7M
ATRC AtriCure, Inc. compare $589.8M
PLSE Pulse Biosciences, Inc $1.5M

What Revenue is

Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.

Reported line item

The full definition of Revenue →

More on PLSE